Healthcare -
Biotechnology - NASDAQ - US
$ 1.39
-2.11 %
$ 161 M
Market Cap
-15.44
P/E
CHRS - GROSS PROFIT
Gross Profit CHRS - Coherus BioSciences, Inc.
94.5 M
LAST VALUE
-40.74%
2 YEAR CAGR
125.46%
5 YEAR CAGR
18.17%
10 YEAR CAGR